Concepedia

Gottfried von Keudell

GV

Statistics

Publications

22

Citations

1.1K

H-Index

18

Active since

2006

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

Cornell University

Charles University

Gottfried von Keudell is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2006–2025

22

Publications

22

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

Connie Lee Batlevi, Fushen Sha, Anna Alperovich et al. · Blood Cancer Journal · 2020 · 185 citations · Full text

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Alison J. Moskowitz, Gunjan L. Shah, Heiko Schöder et al. · Journal of Clinical Oncology · 2021 · 183 citations · Full text

Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies

David Sermer, Connie Lee Batlevi, M. Lia Palomba et al. · Blood Advances · 2020 · 113 citations · Full text

, , +17

Retroviral vector insertion sites associated with dominant hematopoietic clones mark “stemness” pathways

Olga Kustikova, Hartmut Geiger, Zhixiong Li et al. · Blood · 2006 · 95 citations · Full text

Nivolumab for relapsed/refractory classical Hodgkin lymphoma: 5-year survival from the pivotal phase 2 CheckMate 205 study

Stephen M. Ansell, Paul J. Bröckelmann, Gottfried von Keudell et al. · Blood Advances · 2023 · 74 citations · Full text

, , +22

1–5 of 22